Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-12-001892

Options or other derivatives

  • CFO, TREASURER AND SECRETARY acquired 863,511 shares (grant or award)
  • CFO, TREASURER AND SECRETARY returned 1,387,512 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Varvaro Thomas C · CFO, TREASURER AND SECRETARY

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-12-21 Returned to the company : show line 1 in the form Employee Stock Options (right to buy) −645,900 $1.55 2020-05-20 645,900 2,032,600 D
2012-12-21 Returned to the company : show line 2 in the form Employee Stock Options (right to buy) −645,900 $1.55 2020-05-20 645,900 1,386,700 D
2012-12-21 Returned to the company : show line 3 in the form Employee Stock Options (right to buy) −95,712 $1.54 2021-05-10 95,712 1,290,988 D
2012-12-21 Grant or award : show line 4 in the form Employee Stock Options (right to buy) +863,511 $0.95 2022-09-15 863,511 2,154,499 D
Loading xslF345X03/form4-12212012_041221.xml…